Replies to post #784080 on NorthWest Biotherapeutics Inc (NWBO)

[CherryTree1]

It is highly likely IMHO that the purchase of Advent has been a major reason we have not yet received approval.
Maybe we'll see approval next week

[NotSure2]

Wont cross the 5k monthly patient with UK only. SP with UK revenue maybe ~$2.5 - $3.5 if we are lucky and NICE deal within 2-3 years post aproval.

Which means we are quite a few years away from the big $$$...

Unless a buyout of course.